Dowd Kimberly A, Netski Dale M, Wang Xiao-Hong, Cox Andrea L, Ray Stuart C
Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Gastroenterology. 2009 Jun;136(7):2377-86. doi: 10.1053/j.gastro.2009.02.080. Epub 2009 Mar 17.
BACKGROUND & AIMS: Despite recent characterization of hepatitis C virus-specific neutralizing antibodies, it is not clear to what extent immune pressure from neutralizing antibodies drives viral sequence evolution in vivo. This lack of understanding is particularly evident in acute infection, the phase when elimination or persistence of viral replication is determined and during which the importance of the humoral immune response has been largely discounted.
We analyzed envelope glycoprotein sequence evolution and neutralization of sequential autologous hepatitis C virus pseudoparticles in 8 individuals throughout acute infection.
Amino acid substitutions occurred throughout the envelope genes, primarily within the hypervariable region 1 of E2. When individualized pseudoparticles expressing sequential envelope sequences were used to measure neutralization by autologous sera, antibodies neutralizing earlier sequence variants were detected at earlier time points than antibodies neutralizing later variants, indicating clearance and evolution of viral variants in response to pressure from neutralizing antibodies. To demonstrate the effects of amino acid substitution on neutralization, site-directed mutagenesis of a pseudoparticle envelope sequence revealed amino acid substitutions in hypervariable region 1 that were responsible for a dramatic decrease in neutralization sensitivity over time. In addition, high-titer neutralizing antibodies peaked at the time of viral clearance in all spontaneous resolvers, whereas chronically evolving subjects displayed low-titer or absent neutralizing antibodies throughout early acute infection.
These findings indicate that, during acute hepatitis C virus infection in vivo, virus-specific neutralizing antibodies drive sequence evolution and, in some individuals, play a role in determining the outcome of infection.
尽管近期已对丙型肝炎病毒特异性中和抗体进行了特征描述,但尚不清楚中和抗体产生的免疫压力在体内驱动病毒序列进化的程度。这种认识上的不足在急性感染中尤为明显,急性感染是决定病毒复制消除或持续存在的阶段,而在此阶段,体液免疫反应的重要性在很大程度上被忽视了。
我们分析了8名个体在整个急性感染过程中连续的自体丙型肝炎病毒假病毒颗粒的包膜糖蛋白序列进化及中和作用。
整个包膜基因均发生了氨基酸替换,主要发生在E2的高变区1内。当使用表达连续包膜序列的个体化假病毒颗粒来检测自体血清的中和作用时,与中和较晚变异体的抗体相比,在更早的时间点检测到了中和较早序列变异体的抗体,这表明病毒变异体因中和抗体的压力而被清除并发生进化。为了证明氨基酸替换对中和作用的影响,对假病毒颗粒包膜序列进行定点诱变,结果显示高变区1中的氨基酸替换导致中和敏感性随时间急剧下降。此外,在所有自发清除病毒的个体中,高滴度中和抗体在病毒清除时达到峰值,而在慢性进展的个体中,在整个早期急性感染过程中中和抗体滴度较低或不存在。
这些发现表明,在体内丙型肝炎病毒急性感染期间,病毒特异性中和抗体驱动序列进化,并且在一些个体中,在决定感染结局方面发挥作用。